The Spectrum of Ocular Involvement in Systemic Lupus Erythematosus in a Tertiary Eye Care Center in Nepal

REFERENCES

• Foster CS. Ocular manifestations of systemic lupus erythematosus. Accessed January 2009. Available from www.uveitis.org/medical/articles/clinical/ocularman.html.
   Google Scholar
• Osio-Salido1 E, Manapat-Reyes H. Epidemiology of systemic lupus erythematosus in Asia. Lupus. 2010;19:1365–1373.
   PubMedGoogle Scholar
• Gold DH, Morris DA, Henkind P. Ocular findings in systemic lupus erythematosus. Br J Ophthalmol. 1972;56: 800–804.
   PubMed Web of Science ®Google Scholar
• Sivaraj R, Durrani OM, Denniston AK, et al. Ocular manifestations of systemic lupus erythematosus (review). Rheumatology. 2007;46(12):1757–1762.
   Google Scholar
• Tan EM, Cohen AS, Fries JF. The 1982 revised criteria for classification of systemic lupus erythematosus. Arthritis Rheum. 1982; 25:1271–1277.
   PubMed Web of Science ®Google Scholar
• Christie M Bartels. Systemic lupus erythematosus. Accessed February 2008. Available at emedicine.medscape.com/article/332244-diagnosis.
   Google Scholar
• Ushiyama O, Ushiyama K, Koarada S, et al. Retinal disease in patients with systemic lupus erythematosus. Ann Rheum Dis. 2000;59:705–708
   PubMed Web of Science ®Google Scholar
• Nguyen QD, Foster CS. Systemic lupus erythematosus and the eye. Int Ophthalmol Clin. 1998;38:33–60.
   PubMedGoogle Scholar
• Read RW. Clinical mini-review: systemic lupus erythematosus and the eye. Ocul Immunol Inflamm. 2004;12(2):87–99.
   Google Scholar
• Farris RL. Sjogren’s syndrome. In: Gold, DH, Weingeist, TA. (Eds.), The Eye in Systemic Disease. Philadelphia: JB Lippincott; 1990:70–71.
   Google Scholar
• American Academy of Ophthalmology. Intraocular inflammation and uveitis, Basic and Clinical Science Course, Section 9: Chapter 7. American Academy of Ophthalmology; 2010–2011: p.173.
   Google Scholar
• Shern MA, Pirofsky B. Disseminated lupus erythematosus: analysis of thirty-four cases. Arth Intern Med. 1952; 90:790.
   Google Scholar
• Stafford Brady JF, Urowitz MB, Gladman DD, et al. Lupus retinopathy: patterns, associations and prognosis. Arhthritis Rheum. 1988 Sep; 31: (9) 1105–1110.
   PubMedGoogle Scholar
• Arevalo JF, Lowder CY, Muci-Mendoza R. Ocular manifestations manifestations of systemic lupus erythematosus. Curr Opin Ophthalmol. 2002;13:404–410.
   PubMedGoogle Scholar
• Sahu DK. An unusual presentation of lupus retinopathy. Indian J Ophthalmol. 2008;56:72–73.
   PubMedGoogle Scholar
• Chang P-C, Chen W-S, Lin H, et al. Combined central retinal artery and venous occlusion in a patient with systemic lupus erythematosus and antiphospholipid syndrome. Lupus. 2010;19:206–209.
   PubMedGoogle Scholar
• Nguyen QD, Uy HS, Akpek EK, et al. Choroidopathy of systemic lupus erythematosus. Lupus. 2000;9:288–298.
   PubMed Web of Science ®Google Scholar
• Sagduyu A, Çelebisoy N, Yünten N, et al. Optic neuropathy and chiasmopathy as presenting manifestations of systemic lupus erythematosus. Neuro-Ophthalmology. 2004;28;(4) 183–186.
   Google Scholar
• Saleh Z, Menassa J, Abbas O, et al. Cranial nerve VI palsy as a rare initial presentation of systemic lupus erythematosus. Lupus. 2010;19:201–205.
   PubMedGoogle Scholar
• Young CI, Kim SS, Kim HK. Bilateral optic neuritis as first manifestation of systemic lupus erythematosus. Ann Ophthalmol.1978;10:559–563.
   PubMedGoogle Scholar
• Reddy CV, Foster CS. Systemic lupus erythematosus. In Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmology. Philadelphia:WB Saunders; 1994:2894– 2901.
   Google Scholar
• Montehermoso A, Cervera R, Font J. Association of Antiphospholipid antibodies with retinal vascular disease in systemic lupus erythematosus. Semin Arthritis Rheum. 1999;28:326–332.
   PubMed Web of Science ®Google Scholar
• Levine SR, Deegan MJ, Futrell N, et al. Cerebrovascular and neurologic disease associated with antiphospholipid antibodies. Neurology.1990;40:1181–1189.
   PubMed Web of Science ®Google Scholar
• Levine SR, Welch KM. The spectrum of neurologic disease associated with antiphospholipid antibodies: lupus anticoagulants and anticardiolipin antibodies. Arch Neurol. 1987;44:876–883.
   PubMedGoogle Scholar
• Kleiner RC, Najarian LV, Schatten S, et al. Vasoocclusive retinopathy associated with antiphospholipid antibodies (lupus anticoagulant retinopathy). Ophthalmology. 1989;96:896–904.
   PubMed Web of Science ®Google Scholar
• Hughes JR, Davies JA. Anticardiolipin antibodies in clinical conditions associated with a risk of thrombotic events. Thromb Res. 1998;89:101–106.
   PubMedGoogle Scholar
• Golstein M, Meyer O, Bourgeois P. Neurological manifestations of systemic lupus erythematosus: role of antiphospholipid antibodies. Clin Exp Rheumatol. 1993;11: 373–379.
   PubMedGoogle Scholar
• Yap EY, Au Eong KG, Fong KY, et al. Ophthalmic manifestations in Asian patients with systemic lupus erythematosus. Singapore Med J. 1998;39:557–559.
   PubMedGoogle Scholar
• Al Saleh J., Jassim V. Clinical and immunological manifestations in 151 SLE patients living in Dubai. Lupus. 2008;17:62–66.
   PubMedGoogle Scholar
• Soo MP, Chow SK, Tan CT, et al. The spectrum of ocular involvement in patients with systemic lupus erythematosus without ocular symptoms. Lupus. 2000;9: 511–514.
   PubMed Web of Science ®Google Scholar